The Limited Times

Now you can see non-English news...

Pharmacy: Novartis plans to sell its generics

2021-10-26T18:55:44.418Z

Like most Big Pharma, the Swiss group is refocusing its activity on innovative drugs. After having floated its Alcon subsidiary, specializing in ophthalmology, on the stock market in 2019, Novartis is considering parting with Sandoz, its generic drug business. The Swiss giant announced on Tuesday "to start a strategic review" which should continue until the end of 2022. "It is the right time to ask what is the best option for this activity", declared Vas Narasimhan, the CEO of Nova



After having floated its Alcon subsidiary, specializing in ophthalmology, on the stock market in 2019, Novartis is considering parting with Sandoz, its generic drug business.

The Swiss giant announced on Tuesday

"to start a strategic review"

which should continue until the end of 2022.

"It is the right time to ask what is the best option for this activity",

declared Vas Narasimhan, the CEO of Novartis, presenting the laboratory's quarterly results.

Read also

The call for help from generic drug manufacturers

Novartis has been working on the future of this division, which represents 18.5% of its turnover for several years.

Upon his arrival at the head of the group in February 2018, Vas Narasimhan had undertaken to refocus Big Pharma around innovative drugs.

The activity requires increasingly costly and risky R&D investments.

63% of Novartis sales now come from its first twenty drugs.

In September 2018, the laboratory had already attempted to prune the

This article is for subscribers only.

You have 73% left to discover.

To cultivate one's freedom is to cultivate one's curiosity.

Continue reading your article for € 1 the first month

I ENJOY IT

Already subscribed?

Log in

Source: lefigaro

All business articles on 2021-10-26

You may like

News/Politics 2021-11-04T10:24:50.615Z
News/Politics 2021-10-21T06:52:47.077Z
Business 2021-10-26T18:55:44.418Z

Trends 24h

Business 2021-12-03T09:37:20.201Z
Business 2021-12-03T19:51:24.949Z
Business 2021-12-03T08:48:58.177Z

Latest

© Communities 2019 - Privacy